FDA Approved Treatment for Painful Intercourse (Dyspareunia) Due to... (osure of that drug or ospemifene. C...)

FDA Approved Treatment for Painful Intercourse (Dyspareunia) Due to Menopause

Date:2/27/2013

osure of that drug or ospemifene.

Click here for the U.S. Full Prescribing Information for Osphena (ospemifene) tablets, including Boxed WARNING and Patient Information. For more information, please visit http://www.Osphena.com.

Indications and Usage for Osphena™ (ospemifene) tablets

Osphena™ (ospemifene) is indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause.

About Shionogi
Shionogi Inc. is the U.S.-based subsidiary of Shionogi & Co., Ltd., headquartered in Osaka, Japan. Shionogi & Co., Ltd. is a major research-driven pharmaceutical company dedicated to placing the highest value on patients. Shionogi’s research and development currently targets three therapeutic areas: infectious diseases, pain, and metabolic syndrome. In addition, Shionogi is engaged in new research areas such as allergy and cancer. Contributing to the health of patients around the world through development in these therapeutic areas is Shionogi’s primary goal. For more details, please visit http://www.shionogi.co.jp. For more information on Shionogi Inc., headquartered in Florham Park, NJ, please visit http://www.shionogi.com.

###

Read the full story at http://www.prweb.com/releases/2013/2/prweb10456310.htm.

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. ASHA Approved Continuing Education Provider HomeCEUConnection.com Announces Two New Live, Interactive Webinars for California Speech-Language Pathologists.
2. EzW2Correction Software Was Approved By SSA To Print W-2C and W-3C On White Paper
3. Newly approved oral medication slows rheumatoid arthritis joint damage
4. Westbridge Agricultural Products Announces that Botector® has been EPA Approved as an Organic Biopesticide to Prevent Gray Mold in Grapes
5. First FDA approved subcutaneous implantable defibrillator available for patients
6. Not all lung cancer patients who could benefit from crizotinib are identified by FDA-approved test
7. Moffitt Cancer Center melanoma expert reviews unique adverse events with newly approved drug
8. AGA releases first independently developed ABIM-approved Practice Improvement Module in GI
9. Mayo Clinic offers newly approved treatment for acid reflux disease
10. Experimental Vitiligo Treatment Shows Promise in Mice
11. DNDi receives BBVA Foundation award for delivering new treatments for neglected diseases

Post Your Comments:

(Date:5/20/2013)... (PRWEB) May 20, 2013 When a shopper ... is only part of the process. Much of the stress ... internet involves not knowing what to expect. Best Mattress ... consumers can use to ensure their purchase proves smooth. , ... Buy a Mattress Online ”, readers find helpful tips divided ...

(Date:5/20/2013)... (PRWEB) May 20, 2013 The new ... lives and health of all Americans. However, not all ... immediate impact as some might take up to 2014 ... Human Services (HHS), some states are currently moving forward ... Insurance Marketplaces, such as: Iowa, Michigan, New Hampshire, and ...

(Date:5/20/2013)... May 20, 2013 In order to prepare ... and wellness team from DrSmartphoneMD launched an article series to ... , The series launched with the precautions that ... of the DrSmartphoneMD program are not one of the 3.5 ... that more than 90% of all skin cancer cases are ...

(Date:5/20/2013)... Mombo from Comfort & Harmony was ... Lactation Consultant Association (USLCA) May 2nd – 5th. The ... health professionals. , The USLCA annual conference is ... and learn about the latest trends in lactation. ... pillows, which new mothers use to help support infants ...

(Date:5/20/2013)... Leading facial plastic surgeon and ENT specialist Dr. ... Doc” in the field of Otolaryngology in the May/June 2013 ... Beacher magazine, one of Palm Beach County’s leading lifestyle publications, ... 2013 issue, including 70 of the very best physicians in ... to do, health and fitness, people to watch, top doctors, ...

Breaking Medicine News(10 mins):Health News:See What to Expect When You Buy a Mattress Online With Latest Guide From Best Mattress Online 2 Health News:Review of Health Bill Impact in 2014 2 Health News:Review of Health Bill Impact in 2014 3 Health News:Combat Skin Cancer In Summer Months 2 Health News:Comfort & Harmony™ Exhibited mombo™ Nursing Pillow at USLCA’s First Inaugural Conference 2 Health News:Dr. Schwartz Named “Top Doc” by The Palm Beacher Magazine 2

[0] See What to Expect When You Buy a Mattress Online With Latest Guide From Best Mattress Online [0] Review of Health Bill Impact in 2014 [0] Combat Skin Cancer In Summer Months [0] Comfort & Harmony™ Exhibited mombo™ Nursing Pillow at USLCA’s First Inaugural Conference [0] Dr. Schwartz Named “Top Doc” by The Palm Beacher Magazine

... PARIS and MARSEILLE, France, January 11 The,INSTITUT CURIE ... collaboration agreement in the breast cancer domain. Within the,framework of ... Genomic, HER2 and HR tests will be increased thanks to ... the Institut,Curie. The aim of this collaboration is to evaluate ...

... , CHICAGO, Jan. 11 ... Allscripts Stimulus Program , making it safe and easy for ... will qualify for significant federal incentives. , (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ... with a guarantee that the Allscripts EHR they select will ...

... , , ... 11 Allscripts (Nasdaq: MDRX ) announced today ... Electronic Health Record (EHR) and Practice Management solution ... of 51 family practice and internal medicine physicians. The new service ...

... Dr. Siegal,s COOKIE DIET success ... on ABC,s Good Morning America on January 8, 2010 , ... New York, NY (PRWEB) January 11, 2010 -- Marty Moorehead, who weighed in ... an appearance on ABC,s Good Morning America last Friday, feeling and looking like a new man, ...

... ... world by simply spelling correctly the Hebrew word Sun ( SheMeSh éÞé) in English ... , ... After 20 years of research, Joseph Lanyadoo concludes that language was neither invented ...

... , CHICAGO, Jan. 10 ... financial results for the three and six months ended November 30, ... Second Quarter Highlights: , Total revenue of $169.3 ... of $0.10 cents; non-GAAP earnings per share of $0.16 cents ...

The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management Happy New Year for Marty: Arizona Man Drops 164 Pounds on Dr. Siegal's COOKIE DIET and Appears on ABC's Good Morning America New 20 Year Research Confirms the Biblical Assertion that Hebrew is the Original Proto-Language Confounded By the Gods Allscripts Reports Fiscal 2010 Second Quarter Results

(Date:5/20/2013)... announced today the presentation of results from a new ... among diabetic patients in the U.S. than previously recognized. ... both type 1 and type 2 diabetes, but this ... common type 2 disease. Lee ... Medicine at Harvard Medical School and Director of the ...

(Date:5/20/2013)... , May 20, 2013 AbbVie (NYSE: ... a Phase 3 clinical study called SONAR (Study ... effects of the investigational compound atrasentan - when added ... disease in patients with stage 2 to 4 ... SONAR is a large, multinational, double-blind, placebo-controlled clinical ...

(Date:5/19/2013)... 20, 2013 Claret Medical, Inc. announced the publication ... Mieghem et al., Histopathology of Embolic Debris ... print in Circulation, May 7 th this research is ... Rotterdam, the Netherlands and the pathology team ... Cardiovascular Pathology Institute, Gaithersburg, Maryland. This is ...

Breaking Medicine Technology:Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 2 Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 3 Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 4 AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2 AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3 AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4 AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5 AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6 Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR 2

[0] Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S.[0] AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy [0] Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR

... Belgium , July 15, 2010 , ... - Paper Highlights the Potential of ... , , ... the discovery and development of innovative treatments for eye,disease, vascular disease and cancer, ...

... LAKE FOREST, Ill. , July 14 ... focused exclusively on the health-care industry, announced today that ... one of its portfolio companies, Bioniche Pharma Holdings Limited ... generic and specialty pharmaceutical company, for $550 million ...

Cached Medicine Technology:ThromboGenics Announces Publication of Positive Microplasmin Phase II Data in the Journal Retina 2 ThromboGenics Announces Publication of Positive Microplasmin Phase II Data in the Journal Retina 3 ThromboGenics Announces Publication of Positive Microplasmin Phase II Data in the Journal Retina 4 ThromboGenics Announces Publication of Positive Microplasmin Phase II Data in the Journal Retina 5 RoundTable Healthcare Partners Announces Sale of Bioniche Pharma Holdings Limited to Mylan Inc. 2 RoundTable Healthcare Partners Announces Sale of Bioniche Pharma Holdings Limited to Mylan Inc. 3

ThromboGenics Announces Publication of Positive Microplasmin Phase II Data in the Journal Retina RoundTable Healthcare Partners Announces Sale of Bioniche Pharma Holdings Limited to Mylan Inc.

Manufacturer of the WellPro since 1992, ProGroup previously distributed the instrument through Denley and Labsystems. A direct replacement for the ProPette the WellPro performs serial dilutions in an...

Wellpro 96 an automated liquid handling system for 96-well plates that quickly and accurately prepares large quantities of serial dilutions. The Wellpro also performs plate to plate transfers using ...

... aliquot! The aliquot from Genetix is a ... 96, 384, and 1536 well microplates. With ... facility and optional microplate stacker, the aliquot ... volume dispensing needs. The aliQuot's compact design ...

... The Aquarius 384 is a compact ... 384-well head is a unique flow-through ... using the included wash system. ... microplate stacker system. Will be ...

Medicine Products:

WellPro Automated Liquid Handler tm Wellpro 96 AliQuot Aquarius 384 Multichannel Pipettor